Trial intelligence / Profile preview

HIV and Malaria Interactions in African Children

NCT00527800Phase 3Completed

Sponsor
University of California, San Francisco
Start
Aug 2007
Primary completion
Mar 2013
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dihydroartemisinin + piperaquine, trimethoprim + sulfamethoxazole in malaria, sponsored by University of California, San Francisco. Started Aug 2007; status: completed.

02

Drugs

dihydroartemisinin + piperaquinetrimethoprim + sulfamethoxazole
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00527800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00527800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call